Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 21;11(6):1723.
doi: 10.3390/jcm11061723.

Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review

Affiliations
Review

Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review

Lidia Carvajal-Moreno et al. J Clin Med. .

Abstract

Background: Diabetic peripheral neuropathy (DPN) is the most frequent chronic complication and is that which generates the highest disability and mortality in diabetes mellitus (DM). As it is currently the only microvascular complication of DM without a specific treatment, prevention is essential. The aim of this study was to determine the most effective preventive strategy to avoid or delay the appearance and/or development of DPN in patients with DM. Methods: A systematic search was carried out in the main health science databases (PubMed, Scopus, CINAHL, PEDro and The Cochrane Library) from 1 January 2010 to 31 August 2020. The study selection was conducted by two independent reviewers and data extraction was performed by the author. The eligibility criteria included randomized clinical trials (RCTs) and cohort studies from RCTs. Results: Eleven studies were selected that included 23,595 participants with DM. The interventions evaluated were intensive or standard glycemic control, the use of drugs to achieve glycemic control, and the promotion of a healthy lifestyle and exercise. Intensive glucose control achieved a significant reduction in the development of DPN in TIDM patients, and lifestyle modifications and exercise achieved it moderately in TIIDM patients. Conclusions: The main preventive strategy for DPN is intensive glycemic control with a target HbA1c < 6% in patients with TIDM and standard control of 7.0−7.9 in patients with TIIDM, incorporating lifestyle modifications.

Keywords: diabetes mellitus; diabetic complications; diabetic neuropathy; evidence; prevention and control; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram adapted with permission from the PRISMA group, 2020.
Figure 2
Figure 2
Risk of biases of included studies, overall analysis.
Figure 3
Figure 3
Risk of biases of the included studies [15,53,54,55,56,57,58,59,60,61,62], individual analysis. Green: low risk, yellow: unclear risk, red: high risk.

Similar articles

References

    1. Crespo C., Brosa M., Soria-Juan A., López-Alba A., López-Martínez N., Soria B. Costes directos de la diabetes mellitus y de sus complicaciones en España (Estudio SECCAID): Spain estimated cost Ciberdem-Cabimer in diabetes) Av. Diabetol. 2015;29:182–189. doi: 10.1016/j.avdiab.2013.07.007. - DOI
    1. García-Soidán F.J., Villoro R., Merino M., Hidalgo-Vega A., Hernando-Martín T., González-Martín-Moro B. Estado de salud, calidad de vida y utilización de recursos sanitarios de los pacientes con diabetes mellitus en España. Semergen. 2017;43:416–424. doi: 10.1016/j.semerg.2016.06.004. - DOI - PubMed
    1. Smith S.C., Lamping D.L., Maclaine G.D.H. Measuring health-related quality of life in diabetic peripheral neuropathy: A systematic review. Diabetes Res. Clin. Pract. 2012;96:261–270. doi: 10.1016/j.diabres.2011.11.013. - DOI - PubMed
    1. Botas-Velasco M., Cervell-Rodríguez D., Rodríguez-Montalbán S., Jiménez V.A.I., Fernández-de-Valderrama-Martínez I. Actualización en el diagnóstico, tratamiento y prevención de la neuropatía diabética periferica. Angiología. 2017;69:174–181. doi: 10.1016/j.angio.2016.06.005. - DOI
    1. Feldman E.L., Callaghan B.C., Pop-Busui R., Zochodne D.W., Wright D.E., Bennett D.L., Bril V., Russell J.W., Viswanathan V. Diabetic neuropathy. Nat. Rev. Dis. Primers. 2019;5:41. doi: 10.1038/s41572-019-0092-1. - DOI - PubMed